Evidence map›Paper›PMID 30541937›Full record

ArticleJournal of clinical microbiology2019

Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.

Onya Opota, Fathiah Zakham, Jesica Mazza-Stalder, Laurent Nicod, Gilbert Greub, Katia Jaton

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Clinical management of XpertBMC infectious diseases · 2026
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Onya OpotaInstitute of Microbiology, University of Lausanne, University Hospital of Lausanne, Lausanne, Switzerland onya.opota@chuv.ch.
Fathiah ZakhamInstitute of Microbiology, University of Lausanne, University Hospital of Lausanne, Lausanne, Switzerland.
Jesica Mazza-StalderPneumology Service, University Hospital of Lausanne, Lausanne, Switzerland.
Laurent NicodPneumology Service, University Hospital of Lausanne, Lausanne, Switzerland.
Gilbert GreubInstitute of Microbiology, University of Lausanne, University Hospital of Lausanne, Lausanne, Switzerland.
Katia JatonInstitute of Microbiology, University of Lausanne, University Hospital of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xpert MTB/RIF (Xpert) for direct molecular detection of

Indexed as

AdolescentAdultAged, 80 and overAntitubercular AgentsDrug Resistance, BacterialFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedMolecular Diagnostic TechniquesMycobacterium tuberculosisRifampinSensitivity and SpecificitySwitzerlandTuberculosis, PulmonaryAntitubercular AgentsRifampinacid-fast bacilliairborne isolationclinical microbiologydiagnostic microbiologyMycobacterium tuberculosispoint-of-care testsmear microscopytuberculosisXpert MTB/RIFXpert MTB/RIF Ultra

Identifiers

PMID30541937
PMCPMC6355522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.